Education
About Us
Working with TipRanks
Follow Us
FDHT - ETF AI Analysis
Top Page
Fidelity Digital Health ETF (FDHT)
Rating:64Neutral
Price Target:
$23.50
Positive Factors
Strong Top Holdings
Several top holdings, such as Veeva Systems and Hims & Hers Health, have shown strong year-to-date performance, supporting the ETF’s overall gains.
Focused Sector Exposure
The ETF’s heavy allocation to the health care sector provides targeted exposure to a growing and resilient industry.
Reasonable Expense Ratio
With an expense ratio of 0.4%, the ETF offers relatively low costs compared to actively managed funds.
Negative Factors
Underperforming Holdings
Some key positions, such as Intuitive Surgical and Dexcom, have lagged in performance, potentially dragging down returns.
High Sector Concentration
Nearly 90% of the fund is allocated to health care, which increases risk if the sector faces challenges.
Limited Geographic Diversification
The ETF is heavily weighted toward U.S. companies, with limited exposure to international markets, which may reduce global diversification.
FDHT vs. SPDR S&P 500 ETF (SPY)
AUM8.29M
RegionGlobal
Expense Ratio0.39%
Beta0.95
IssuerFidelity
Inception DateOct 05, 2021
Dividend Yield1.61%
Asset ClassEquity
Index TrackedFidelity Digital Health Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,670
30 Day Avg. Volume2,354
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
26.25Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FDHT Summary
The Fidelity Digital Health ETF (FDHT) is an investment fund that focuses on companies using technology to improve healthcare. It includes businesses involved in telemedicine, wearable health devices, and healthcare analytics. Some well-known companies in this ETF are Veeva Systems and Intuitive Surgical. Investors might consider FDHT to gain exposure to the growing digital health market, which is transforming how healthcare is delivered and making it more efficient. However, new investors should be aware that this ETF is heavily focused on healthcare and technology, meaning its performance could be impacted by changes in those industries.
How much will it cost me?The Fidelity Digital Health ETF (FDHT) has an expense ratio of 0.40%, which means you’ll pay $4 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on innovative companies in the digital health sector. Active management often involves higher costs due to research and specialized strategies.
What would affect this ETF?The Fidelity Digital Health ETF (FDHT) could benefit from the growing adoption of technology in healthcare, such as telemedicine and wearable health devices, as well as increased demand for efficient and accessible medical services globally. However, challenges like regulatory changes, cybersecurity risks, or slower-than-expected adoption of digital health solutions could negatively impact its performance. Its focus on innovative healthcare companies and global exposure positions it well for long-term growth, but investors should remain mindful of sector-specific risks.
FDHT Top 10 Holdings
The Fidelity Digital Health ETF is heavily concentrated in the healthcare sector, with a global mix of companies driving innovation in digital health. Intuitive Surgical and Dexcom are lagging, with recent declines reflecting valuation concerns and mixed technical signals, which have weighed on the fund’s performance. On the brighter side, Hims & Hers Health is rising steadily, fueled by strong growth initiatives and international expansion, while Insulet’s robust revenue growth has also provided a lift. Overall, the fund’s focus on cutting-edge health technologies offers long-term promise, though near-term performance remains mixed.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 5.66% | $469.56K | $194.46B | 2.11% | 78 Outperform | |
| Veeva Systems | 5.13% | $425.17K | $48.40B | 23.92% | 81 Outperform | |
| GE Healthcare Technologies Inc | 4.78% | $396.80K | $34.44B | -16.03% | 74 Outperform | |
| Koninklijke Philips N.V. | 4.65% | $386.11K | €23.16B | -1.65% | 56 Neutral | |
| Insulet | 4.26% | $353.12K | $22.13B | 20.67% | 77 Outperform | |
| Siemens Healthineers AG | 3.84% | $318.66K | €50.21B | -6.23% | 79 Outperform | |
| Dexcom | 3.44% | $285.61K | $23.12B | -17.07% | 69 Neutral | |
| Doximity | 2.95% | $244.76K | $11.99B | 7.43% | 70 Outperform | |
| Hims & Hers Health | 2.91% | $241.43K | $9.96B | 77.36% | 68 Neutral | |
| JD Health International, Inc. | 2.90% | $240.38K | HK$192.09B | 100.66% | 75 Outperform |
FDHT Technical Analysis
Negative
―
Price Trends
21.54
Negative
21.24
Negative
20.65
Negative
Market Momentum
-0.27
Positive
28.38
Positive
8.77
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDHT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 21.33, equal to the 50-day MA of 21.54, and equal to the 200-day MA of 20.65, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 28.38 is Positive, neither overbought nor oversold. The STOCH value of 8.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FDHT.
FDHT Peer Comparison
Comparison Results
Performance Comparison
FDHT
Fidelity Digital Health ETF
20.28
-0.22
-1.07%
CANC
Tema Oncology ETF
―
―
―
FMED
Fidelity Disruptive Medicine ETF
―
―
―
HEAL
Global X HealthTech ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents